1. Polypharmacy in elective lumbar spinal surgery for degenerative conditions with 24-month follow-up
- Author
-
Nicholas Dietz, Chitra Kumar, Aladine A. Elsamadicy, Martin F. Bjurström, Katrina Wong, Alysha Jamieson, Mayur Sharma, Dengzhi Wang, Beatrice Ugiliweneza, Doniel Drazin, and Maxwell Boakye
- Subjects
Polypharmacy ,Spine surgery ,Health care utilization ,Complications ,Lumbar Fusion ,Medicine ,Science - Abstract
Abstract We sought to identify long-term associations of medical complications and healthcare utilization related to polypharmacy following spinal surgery for degenerative lumbar pathology. The IBM MarketScan dataset was used to select patients who underwent spinal surgery for degenerative lumbar pathology with 2-year follow-up. Regression analysis compared two matched cohorts: those with and without polypharmacy. Of 118,434 surgical patients, 68.1% met criteria for polypharmacy. In the first 30 days after discharge, surgical site infection was observed in 6% of those with polypharmacy and 4% of those without polypharmacy (p
- Published
- 2024
- Full Text
- View/download PDF